Related references
Note: Only part of the references are listed.Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
Amanda Olson et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Lymphopenia in COVID-19: Therapeutic opportunities
Nazanin Fathi et al.
CELL BIOLOGY INTERNATIONAL (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
Hong-Yi Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
Dandan Wu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
Peter J. Hotez et al.
MICROBES AND INFECTION (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells
Rafet Basar et al.
BLOOD ADVANCES (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun et al.
NATURE (2020)
Immunological and inflammatory profiles in mild and severe cases of COVID-19
Jin-Wen Song et al.
NATURE COMMUNICATIONS (2020)
Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
Constantin J. Thieme et al.
CELL REPORTS MEDICINE (2020)
Adoptive Transfer of Interleukin-21-stimulated Human CD8+ T Memory Stem Cells Efficiently Inhibits Tumor Growth
Yingshi Chen et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Adoptive T Cell Therapy for epstein-Barr virus Complications in Patients with Primary immunodeficiency Disorders
Lauren P. McLaughlin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy
Muharrem Muftuoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
Ifigeneia Tzannou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15
Marie-Laure Clenet et al.
SCIENTIFIC REPORTS (2017)
T cells for viral infections after allogeneic hematopoietic stem cell transplant
Catherine M. Bollard et al.
BLOOD (2016)
Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
R. J. O'Reilly et al.
BONE MARROW TRANSPLANTATION (2016)
Interleukins 7 and 15 Maintain Human T Cell Proliferative Capacity through STAT5 Signaling
Adam Drake et al.
PLOS ONE (2016)
Cytofkit: A Bioconductor Package for an Integrated Mass Cytometry Data Analysis Pipeline
Hao Chen et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Jacob H. Levine et al.
CELL (2015)
Adult haemophagocytic syndrome
Manuel Ramos-Casals et al.
LANCET (2014)
Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry
Britta Eiz-Vesper et al.
FRONTIERS IN IMMUNOLOGY (2013)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response
YQ Li et al.
JOURNAL OF IMMUNOLOGY (2005)
Transition of late-stage effector T cells to CD27(+) CD28(+) tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
DJ Powell et al.
BLOOD (2005)
Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells
J Geginat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
